UGI Stock Analysis: UGI | NYSE
Utilities - Regulated Gas | NYSE, USA | Market Cap: 7.823m USD | 12M Return: 9.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 43.1M
Qual. Beats: 0
Rev. Trend: -77.2%
Qual. Beats: -2
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
UGI Corporation is a King of Prussia, Pennsylvania-based energy company that operates through four segments: Utilities, Midstream & Marketing, UGI International, and AmeriGas Propane. The company is incorporated since 1882 and is classified within the Gas Utilities sub-industry under the GICS Utilities sector.
Its business spans the full energy value chain, including the distribution of propane and liquefied petroleum gases (LPG) to residential, commercial, industrial, agricultural, wholesale, and motor fuel customers. UGIs AmeriGas Propane segment is a major player in the U.S. retail propane market, an industry characterized by a small number of large national distributors serving a fragmented customer base across both heating and non-heating applications.
On the regulated utility side, the company distributes natural gas to customers in eastern and central Pennsylvania through a pipeline and gas main network, and supplies electricity to customers in northeastern Pennsylvania. UGI also operates electric generation, natural gas liquefaction and storage, and rail transshipment infrastructure, blending rate-regulated utility operations with midstream logistics and marketing activities.
- AmeriGas margins track winter heating degree days
- Pennsylvania PUC rate order supports utility earnings
- European LPG demand recovery drives UGI International volumes
| Net Income: 641.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -2.09 > 1.0 |
| NWC/Revenue: 0.05% < 20% (prev 5.96%; Δ -5.90% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.11b > Net Income 641.0m |
| Net Debt (6.30b) to EBITDA (1.47b): 4.30 < 3 |
| Current Ratio: 1.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (222.7m) vs 12m ago 1.72% < -2% |
| Gross Margin: 46.11% > 18% (prev 51.89%; Δ -5.78% > 0.5%) |
| Asset Turnover: 46.19% > 50% (prev 46.48%; Δ -0.29% > 0%) |
| Interest Coverage Ratio: 4.36 > 6 (EBIT TTM 903.0m / Interest Expense TTM 207.0m) |
| A: 0.00 (Total Current Assets 2.51b - Total Current Liabilities 2.51b) / Total Assets 16.1b |
| B: 0.25 (Retained Earnings 3.99b / Total Assets 16.1b) |
| C: 0.06 (EBIT TTM 903.0m / Avg Total Assets 15.9b) |
| D: 0.51 (Book Value of Equity 5.42b / Total Liabilities 10.7b) |
| Altman-Z'' = 1.72 = BBB |
| DSRI: 0.98 (Receivables 1.31b/1.32b, Revenue 7.36b/7.32b) |
| GMI: 1.13 (GM 51.89% / 46.11%) |
| AQI: 0.96 (AQ_t 0.28 / AQ_t-1 0.29) |
| SGI: 1.01 (Revenue 7.36b / 7.32b) |
| TATA: -0.03 (NI 641.0m - CFO 1.11b) / TA 16.1b) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of July 27, 2026, the stock is trading at USD 37.33 with a total of 998,397 shares traded. Over the past week, the price has changed by +1.94%, over one month by +5.36%, over three months by +1.35% and over the past year by +9.13%.
Current recommended Stop Loss: 36.40 (which is 2.5% or 1.3 ATR below the current price).
UGI has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy UGI.
- StrongBuy: 3
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 43.3 | 16.1% |
P/E Trailing = 12.9397
P/E Forward = 7.728
P/S = 1.0631
P/B = 1.4532
P/EG = 48.818
Revenue TTM = 7.36b USD
EBIT TTM = 903.0m USD
EBITDA TTM = 1.47b USD
Long Term Debt = 5.99b USD (from longTermDebt, last quarter)
Short Term Debt = 807.0m USD (from shortTermDebt, last quarter)
Debt = 6.79b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.30b USD (calculated: Debt 6.79b - CCE 494.0m)
Enterprise Value = 14.1b USD (7.82b + Debt 6.79b - CCE 494.0m)
Interest Coverage Ratio = 4.36 (Ebit TTM 903.0m / Interest Expense TTM 207.0m)
EV/FCF = 59.33x (Enterprise Value 14.1b / FCF TTM 238.0m)
FCF Yield = 1.69% (FCF TTM 238.0m / Enterprise Value 14.1b)
FCF Margin = 3.23% (FCF TTM 238.0m / Revenue TTM 7.36b)
Net Margin = 8.71% (Net Income TTM 641.0m / Revenue TTM 7.36b)
Gross Margin = 46.11% ((Revenue TTM 7.36b - Cost of Revenue TTM 3.97b) / Revenue TTM)
Gross Margin QoQ = 43.24% (prev 51.42%)
Tobins Q-Ratio = 0.88 (Enterprise Value 14.1b / Total Assets 16.1b)
Interest Expense / Debt = 3.05% (Interest Expense 207.0m / Debt 6.79b)
Taxrate = 7.90% (55.0m / 696.0m)
NOPAT = 831.6m (EBIT 903.0m * (1 - 7.90%))
Current Ratio = 1.00 (Total Current Assets 2.51b / Total Current Liabilities 2.51b)
Debt / Equity = 1.25 (Debt 6.79b / totalStockholderEquity, last quarter 5.42b)
Debt / EBITDA = 4.30 (Net Debt 6.30b / EBITDA 1.47b)
Debt / FCF = 26.46 (Net Debt 6.30b / FCF TTM 238.0m)
Total Stockholder Equity = 5.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.02% (Net Income 641.0m / Total Assets 16.1b)
RoE = 12.77% (Net Income TTM 641.0m / Total Stockholder Equity 5.02b)
RoCE = 8.21% (EBIT 903.0m / Capital Employed (Equity 5.02b + L.T.Debt 5.99b))
RoIC = 5.92% (NOPAT 831.6m / Invested Capital 14.1b)
WACC = 4.86% (E(7.82b)/V(14.6b) * Re(6.64%) + D(6.79b)/V(14.6b) * Rd(3.05%) * (1-Tc(0.08)))
Discount Rate = 6.64% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 78.75 | Cagr: 1.46%
[DCF] Terminal Value 73.10% ; FCFF base≈367.2m ; Y1≈322.0m ; Y5≈260.2m
[DCF] Fair Price = N/A (negative equity: EV 4.18b - Net Debt 6.30b = -2.12b; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.15 | # QB: 0
Revenue Correlation: -77.21 | Revenue CAGR: -7.63% | SUE: -1.40 | # QB: -2
EPS current Quarter (2026-06-30): EPS=-0.18 | Chg30d=-350.00% | Revisions=+0% | Analysts=2
EPS current Year (2026-09-30): EPS=2.81 | Chg30d=+0.54% | Revisions=-40% | GrowthEPS=-15.2% | GrowthRev=-1.1%
EPS next Year (2027-09-30): EPS=3.33 | Chg30d=-0.20% | Revisions=-40% | GrowthEPS=+18.4% | GrowthRev=+9.0%
[Analyst] Revisions Ratio: -57% (up=0, down=4)